| Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens ME Dudley, JC Yang, R Sherry, MS Hughes, R Royal, U Kammula, ... Journal of Clinical Oncology 26 (32), 5233, 2008 | 1369 | 2008 |
| Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade SG Downey, JA Klapper, FO Smith, JC Yang, RM Sherry, RE Royal, ... Clinical Cancer Research 13 (22), 6681-6688, 2007 | 627 | 2007 |
| High‐dose interleukin‐2 for the treatment of metastatic renal cell carcinoma: a retrospective analysis of response and survival in patients treated in the surgery branch at the … JA Klapper, SG Downey, FO Smith, JC Yang, MS Hughes, US Kammula, ... Cancer 113 (2), 293-301, 2008 | 358 | 2008 |
| Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer N Zacharakis, H Chinnasamy, M Black, H Xu, YC Lu, Z Zheng, A Pasetto, ... Nature medicine 24 (6), 724-730, 2018 | 334 | 2018 |
| Lymphoma remissions caused by anti-CD19 chimeric antigen receptor T cells are associated with high serum interleukin-15 levels JN Kochenderfer, RPT Somerville, T Lu, V Shi, A Bot, J Rossi, A Xue, ... Journal of Clinical Oncology 35 (16), 1803, 2017 | 291 | 2017 |
| Treatment of metastatic melanoma using interleukin-2 alone or in conjunction with vaccines FO Smith, SG Downey, JA Klapper, JC Yang, RM Sherry, RE Royal, ... Clinical Cancer Research 14 (17), 5610-5618, 2008 | 267 | 2008 |
| Randomized, prospective evaluation comparing intensity of lymphodepletion before adoptive transfer of tumor-infiltrating lymphocytes for patients with metastatic melanoma SL Goff, ME Dudley, DE Citrin, RP Somerville, JR Wunderlich, ... Journal of Clinical Oncology 34 (20), 2389, 2016 | 199 | 2016 |
| Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study SS Chandran, RPT Somerville, JC Yang, RM Sherry, CA Klebanoff, ... The Lancet Oncology 18 (6), 792-802, 2017 | 123 | 2017 |
| Treatment of patients with metastatic cancer using a major histocompatibility complex class II–restricted T-cell receptor targeting the cancer germline antigen MAGE-A3 YC Lu, LL Parker, T Lu, Z Zheng, MA Toomey, DE White, X Yao, YF Li, ... Journal of Clinical Oncology 35 (29), 3322, 2017 | 103 | 2017 |
| Tumor infiltrating lymphocyte therapy for metastatic melanoma: analysis of tumors resected for TIL SL Goff, FO Smith, JA Klapper, R Sherry, JR Wunderlich, SM Steinberg, ... Journal of immunotherapy (Hagerstown, Md.: 1997) 33 (8), 840, 2010 | 98 | 2010 |
| Adoptive cell therapy—tumor-infiltrating lymphocytes, T-cell receptors, and chimeric antigen receptors SA Feldman, Y Assadipour, I Kriley, SL Goff, SA Rosenberg Seminars in oncology 42 (4), 626, 2015 | 66 | 2015 |
| Risk of bowel perforation in patients receiving interleukin-2 after therapy with anti-CTLA 4 monoclonal antibody FO Smith, SL Goff, JA Klapper, C Levy, T Allen, SA Mavroukakis, ... Journal of immunotherapy (Hagerstown, Md.: 1997) 30 (1), 130, 2007 | 50 | 2007 |
| Pilot trial of adoptive transfer of chimeric antigen receptor transduced T cells targeting EGFRvIII in patients with glioblastoma SL Goff, RA Morgan, JC Yang, RM Sherry, PF Robbins, NP Restifo, ... Journal of immunotherapy (Hagerstown, Md.: 1997) 42 (4), 126, 2019 | 42 | 2019 |
| Post-shunt resource consumption favors small-diameter prosthetic H-graft portacaval shunt over TIPS for patients with poor hepatic reserve AS Rosemurgy, EE Zervos, M Bloomston, AJ Durkin, WC Clark, S Goff Annals of surgery 237 (6), 820, 2003 | 38 | 2003 |
| Enhanced receptor expression and in vitro effector function of a murine-human hybrid MART-1-reactive T cell receptor following a rapid expansion SL Goff, LA Johnson, MA Black, H Xu, Z Zheng, CJ Cohen, RA Morgan, ... Cancer immunology, immunotherapy 59 (10), 1551-1560, 2010 | 37 | 2010 |
| Unique neoantigens arise from somatic mutations in patients with gastrointestinal cancers MR Parkhurst, PF Robbins, E Tran, TD Prickett, JJ Gartner, L Jia, G Ivey, ... Cancer discovery 9 (8), 1022-1035, 2019 | 36 | 2019 |
| Characterization of an immunogenic mutation in a patient with metastatic triple-negative breast cancer Y Assadipour, N Zacharakis, JS Crystal, TD Prickett, JJ Gartner, ... Clinical Cancer Research 23 (15), 4347-4353, 2017 | 24 | 2017 |
| Neoadjuvant therapy for non-metastatic pancreatic ductal adenocarcinoma M Winner, SL Goff, JA Chabot Seminars in oncology 42 (1), 86-97, 2015 | 22 | 2015 |
| Metastasectomy following immunotherapy with adoptive cell transfer for patients with advanced melanoma ND Klemen, PL Feingold, SL Goff, MS Hughes, US Kammula, JC Yang, ... Annals of surgical oncology 24 (1), 135-141, 2017 | 20 | 2017 |
| No correlation between clinical response to CTLA-4 blockade and presence of NY-ESO-1 antibody in patients with metastatic melanoma SL Goff, PF Robbins, M El-Gamil, SA Rosenberg Journal of immunotherapy (Hagerstown, Md.: 1997) 32 (8), 884, 2009 | 20 | 2009 |
Steven A RosenbergNCIVerified email at nih.gov
